{"id":"W2597425187","doi":"10.1200/jco.2013.31.15_suppl.tps4594","title":"A phase II multicenter study of the efficacy and safety of sunitinib given on an individualized schedule as first-line therapy for metastatic renal cell cancer.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baker Hughes (Canada); Cancer Care Ontario; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; Ozmosis Research (Canada); Lakeridge Health; Ottawa Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Toxicity; Sunitinib; Internal medicine; Phases of clinical research; Urology; Oncology; Cancer; Gastroenterology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00374715,0.002131504,0.002756477,0.0006672547,0.0007733738,0.0009825578,0.001299852,0.001115053,0.003757195],"category_scores_gemma":[0.001471134,0.0009938835,0.001549317,0.0006797749,0.001613279,0.00104822,0.0005513786,0.003038989,0.0008945646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001436732,"about_ca_system_score_gemma":0.00243507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001703348,"about_ca_topic_score_gemma":0.00259092,"domain_scores_codex":[0.9986752,0.0007225049,0.00005778223,0.000236432,0.0001265544,0.0001815258],"domain_scores_gemma":[0.998175,0.0002051034,0.0004416696,0.0002398638,0.00009416792,0.00084415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.814107,0.09898829,0.01413804,0.0003660044,0.001128432,0.0002067419,0.0003133495,0.002536501,0.02905316,0.0001284346,0.001682536,0.03735151],"study_design_scores_gemma":[0.4571448,0.5205401,0.01765904,0.00001098468,0.000389996,0.0002082456,0.00005639495,0.000814039,0.002318726,0.00007867906,0.0007547113,0.00002431898],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958479,0.0004317959,0.0004068716,0.0001271314,0.00006908253,0.002074881,0.00051881,0.00005184098,0.0004715615],"genre_scores_gemma":[0.9912197,0.0004611034,0.002086722,0.0003080306,0.0001445296,0.00308044,0.001596632,0.00003221258,0.001070683],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003757195,"threshold_uncertainty_score":0.01981705,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1703396574996059,"score_gpt":0.4865881048625481,"score_spread":0.3162484473629421,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}